Trending

#THERAPEUTICS

Latest posts tagged with #THERAPEUTICS on Bluesky

Latest Top
Trending

Posts tagged #THERAPEUTICS

Post image

Join the CARB-X team for public webinars to learn more about the 2026 funding round, seeking #preventatives, #therapeutics, and #diagnostics to address AMR. #IDSky #ChemSky 🧪
📆 9 April at 17:30 ET
🔗 Register: bit.ly/4aPGbWR

📆 10 April at 09:00 ET
🔗 Register: bit.ly/4u8u6DR

1 1 0 0
Post image

🚨 Just one month left to apply for our second NeuroAdapt MSCA Fellowship!

Join FutureNeuro and help advance cutting-edge research in #Diagnostics, #Therapeutics, and #DigitalHealth for brain conditions.

👉 Apply by 10 April: futureneurocentre.ie/neuroadapt/a...

0 0 0 0
Post image

🎓 Trainees & Young Investigators: Funding is available to attend the 18th Int'l Conference on #Complement #Therapeutics May 27–June 1, 2026 Sissi, Crete 🇬🇷
📢 Submit your abstract and join us!
🔗 www.aegeanconferences.org/src/App/conf...
#ComplementTherapeutics #EarlyCareerResearchers #Immunology

0 0 0 0
Preview
Deal aimed at developing therapy to fight toxic protein in ALS... Transition Bio and Voyager have teamed to discover and develop new small molecules that target toxic TDP-43 protein clumps in ALS and FTD.

A new research deal is targeting toxic proteins behind #ALS and #FTD — a hopeful advance in developing therapies that go after the disease mechanisms. 🧬

Read more: https://ow.ly/XsTV50Ym5cx

#NeurodegenerativeDisease #MedicalResearch #Therapeutics #Biotech #HealthNews

0 0 0 0
Post image

Hematopoietic stem cell transplant with a carrier donor rescues CD40L deficiency. New case report from Christen L. Ebens @umnpeds.bsky.social, Amir A. Sadighi Akha @mayoclinic.org and colleagues: rupress.org/jhi/article/...

#InbornErrorsOfImmunity #Therapeutics #HSCT

1 2 0 0
Post image

Funds are still available for Trainee & Young Investigator Travel Awards!
Apply by Feb 28 for the 18th Int'l Conference on #Complement #Therapeutics
📅 05/27/2026 – 06/01/2026
📍 #Sissi, #Crete, #Greece
🏛 #KalimeraKriti Conference Center
Apply here:
aegeanconferences.org/src/App/page...

0 0 0 0

#BPS2026 Newsroom Spotlight - Sometimes Less is More: Scientists Rethink How to Pack Medicine into Tiny Delivery Capsules @nhalzakis @ucph_research #mRNA #vaccines #therapeutics #cancertreatment

2 0 0 0
Original post on mastodon.online

Single Dose of DMT Rapidly Reduces Symptoms of Major Depression

Small Phase IIa study [34 subjects] but some interesting points
"intravenous DMT has a half-life of around five minute"
and
"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive […]

1 2 1 0
Post image

Comprehensive Physiology | Review Spotlight 🔦 This 2025 review highlights T2DM causes, comorbidities, and new therapies, plus a roadmap for future drug discovery. Read: https://ow.ly/R18750YcmSW #Type2Diabetes #DiabetesResearch #Physiology #Therapeutics #HealthyLifestyle

1 0 0 0
Preview
Karyopharm Therapeutics Announces 2025 Financial Results and Key Milestones Ahead Karyopharm Therapeutics has shared its financial results for 2025, highlighting growth, product performance, and key upcoming trials set for 2026.

Karyopharm Therapeutics Announces 2025 Financial Results and Key Milestones Ahead #United_States #Karyopharm #XPOVIO #Newton #Therapeutics

0 0 0 0
Preview
Anticodon-edited transfer RNAs (ACE-tRNAs) encoded as therapeutic nonviral minimal DNA vectors Abstract. Nonsense mutations, resulting from a premature termination codon (PTC), make up ∼11% of all genetic lesions causing disease, affecting millions o

Excited for our most recent study that does a deep dive into therapeutic minivectors that express ACE-tRNAs for treatment of nonsense-associated diseases. The method development here was years in the making. Check it out at NAR! #nonsense #tRNAs #therapeutics #NAR

doi.org/10.1093/nar/...

0 0 0 0
Post image

Targeting tau in #AlzheimersDisease: rationale, approach and challenges

Aram Aslanyan, Martha S. Foiani, Tatiana A. Giovannucci...Ross W. Paterson @ukdri.ac.uk #biomarkers #therapeutics

link.springer.com/article/10.1...

0 0 0 0
Post image

Abstract Submission, Travel Award Applications, and Early Fee Deadline Extended to February 28. Join us at the 18th Int'l Conference on #Complement #Therapeutics www.aegeanconferences.org/src/App/conf... #Crete #Greece May 27-June 1, 2026 #ComplementTherapeutics

1 0 0 0
Post image

Today is #WorldNeglectedTropicalDiseasesDay. We stand with the #WHO to Unite, Act, Eliminate. New #therapeutics are an essential part of achieving this.

www.who.int/campaigns/wo...

0 0 0 0
Green synthesis of alginate-encapsulated silver nanoparticles and its utilization as anticancer and antimicrobial therapeutics

Green synthesis of alginate-encapsulated silver nanoparticles and its utilization as anticancer and antimicrobial therapeutics

Scientists develop green-synthesized alginate-encapsulated #AgNPs from C. fistula that show dual #anticancer and #antimicrobial activity, highlighting their promise as multitargeted #therapeutics for #cancer and #MicrobialDiseases.
Nanotechnology Reviews: doi.org/10.1515/ntre...

0 0 0 0
Preview
DUB Inhibitors Market Expected to Experience Significant Growth by 2040 with Innovative Therapeutics Advancements The DUB inhibitors market is set for remarkable growth driven by innovative therapies targeting cancer and neurodegenerative diseases. Insights from key trends and market forecasts reveal future opportunities.

DUB Inhibitors Market Expected to Experience Significant Growth by 2040 with Innovative Therapeutics Advancements #None #oncology #Therapeutics #DUB_inhibitors

0 0 0 0
Preview
Halozyme Therapeutics Increases Revenue Estimates Through 2025 and Beyond with New Acquisition Halozyme Therapeutics has raised its revenue estimates for 2025 and set ambitious financial guidance for 2026, driven by innovative acquisitions and strong royalty growth.

Halozyme Therapeutics Increases Revenue Estimates Through 2025 and Beyond with New Acquisition #United_States #San_Diego #Halozyme #Therapeutics #ENHANZE

0 0 0 0
Check out the 2024 edition on the latest research into Antiphospholipid Syndrome (APS), a rare autoimmune disease that causes the blood to clot.

Check out the 2024 edition on the latest research into Antiphospholipid Syndrome (APS), a rare autoimmune disease that causes the blood to clot.

" #Researchers are still trying to understand the full role of β2GPI as well as #AntiphospholipidSyndrome. So whilst these #therapeutics sound exciting, it will probably still be many years before we see them in practice.": buff.ly/r5TlLCA

#MedSky #ChronicIllness

7 2 0 0
Post image Post image Post image

Impact of Kellgren–Lawrence grade on clinical outcomes following adipose-derived stem cell therapy for knee osteoarthritis: A propensity score–matched retrospective cohort study
@celltransplant1992.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#regeneration #therapeutics

0 0 0 0
Preview
Arkin Bio Ventures III: $100 million fund for transformative therapies Fund lead, Dr. Pini Orbach, talks about the fund targeting oncology, immunology, inflammation, rare diseases, and their aim to be an active partner from day one.

Arkin Capital launches $100M Arkin Bio Ventures III to back transformative biotech companies. The fund takes a hands-on, science-driven approach as an active partner from day one.
#News #Interview #Biotech #VentureCapital #Therapeutics #DrugDiscovery

0 0 0 0
Preview
Arkin Bio Ventures III: $100 million fund for transformative therapies Fund lead, Dr. Pini Orbach, talks about the fund targeting oncology, immunology, inflammation, rare diseases, and their aim to be an active partner from day one.

Arkin Capital launches $100M Arkin Bio Ventures III to back transformative biotech companies. The fund takes a hands-on, science-driven approach as an active partner from day one.
#News #Interview #Biotech #VentureCapital #Therapeutics #DrugDiscovery

0 0 0 0
Post image

The longevity biotech expands BGE-102 into diabetic macular edema, betting that aging biology drives vision loss.

longevity.technology/news/bioage-...

#longevity #biotech #drugdevelopment #agingresearch #eyedisease #retina #ophthalmology #geroscience #clinicaltrials #healthspan #therapeutics

0 0 0 0
Post image

New Article Alert from Antibody Therapeutics(IF=4.5, Oxford University Press)
"Recent advances in structural investigations of cancer antigen mesothelin and its interactions with therapeutic antibodies" contributed by NIH.
academic.oup.com/abt/article/...
#Antibody #Therapeutics #Cancer #Antigen

2 1 0 0
Video

👋 Meet Prof Tobias Engel, Programme Director of the NeuroAdapt MSCA COFUND. In this video, he introduces the newly opened Fellowship call and what strong applications should focus on — neuroscience across #Diagnostics, #Therapeutics and #DigitalHealth: futureneurocentre.ie/neuroadapt/a...

2 0 0 0
Post image

🚨 The second Neuroadapt MSCA Fellowship call is now open!

Join FutureNeuro to advance cutting-edge research in #Diagnostics, #Therapeutics and #DigitalHealth for brain conditions.

👉 Learn more and apply by 10 April:
futureneurocentre.ie/neuroadapt/a...

@researchireland.ie @ec.europa.eu

2 2 0 0
Post image

BioAge’s oral drug sharply reduced heart-linked inflammation in just two weeks, adding momentum to the aging-inflammation race.

longevity.technology/news/bioage-...

#longevity #BioAge #NLRP3Inhibitor #ClinicalTrials #Inflammation #Healthspan #BiotechMilestones #AgingScience #Therapeutics

0 0 0 0
Post image

Therapeutics NOW is live!
Submit your manuscripts today and be part of cutting-edge research in therapeutics.
🔗 mc.manuscriptcentral.com/therapeutics...
#OpenAccess #Therapeutics #Research #Publishing

0 1 0 1
Post image

REMINDER: Submit your abstract, trainee award application, and online registration to the 18th Int'l Conference on #Complement #Therapeutics held in #Sissi, #Crete, #Greece from May 27 - June 1, 2026 www.aegeanconferences.org/src/App/conf... #complementtherapeutics

1 0 0 0
The Zero-CAC Phenomenon: How aéPiot Built a Global Network Across 180+ Countries Through Pure Viral Growth. A Comprehensive Business and Marketing Analysis. The Zero-CAC Phenomenon: How aéPiot Built a Global Network Across 180+ Countries Through Pure Viral Growth A Comprehensive Business and M...

better-experience.blogspot.com/2026/01/the-...

#SHADY #ELNAHAS
aepiot.ro/advanced-sea...
#PEPTIDE #THERAPEUTICS
multi-search-tag-explorer.aepiot.ro/advanced-sea...
#JUHAN #PARTS
aepiot.com/advanced-sea...
aepiot.ro

0 0 0 0
Preview
Monkeypox Virus: Epidemiology, Virology, Diagnosis, Vaccine, and Therapeutics This review provides a comprehensive overview of the latest research advances in MPXV, with a focused analysis across five core dimensions: epidemiology, virology, diagnosis, vaccine, and therapeutic...

#Review in #MedComm
#Monkeypox #Virus: Epidemiology, Virology, Diagnosis, Vaccine, and Therapeutics doi.org/10.1002/mco2...

#diagnosis #epidemiology #therapeutics #virology #vaccine

0 0 0 0